GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » Equity-to-Asset

Pulike Biological Engineering (SHSE:603566) Equity-to-Asset : 0.85 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pulike Biological Engineering's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,733 Mil. Pulike Biological Engineering's Total Assets for the quarter that ended in Mar. 2024 was ¥3,205 Mil. Therefore, Pulike Biological Engineering's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.85.

The historical rank and industry rank for Pulike Biological Engineering's Equity-to-Asset or its related term are showing as below:

SHSE:603566' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.79   Med: 0.86   Max: 0.9
Current: 0.85

During the past 13 years, the highest Equity to Asset Ratio of Pulike Biological Engineering was 0.90. The lowest was 0.79. And the median was 0.86.

SHSE:603566's Equity-to-Asset is ranked better than
74.97% of 1558 companies
in the Biotechnology industry
Industry Median: 0.67 vs SHSE:603566: 0.85

Pulike Biological Engineering Equity-to-Asset Historical Data

The historical data trend for Pulike Biological Engineering's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering Equity-to-Asset Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.84 0.83 0.83 0.84

Pulike Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.84 0.82 0.84 0.85

Competitive Comparison of Pulike Biological Engineering's Equity-to-Asset

For the Biotechnology subindustry, Pulike Biological Engineering's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's Equity-to-Asset falls into.



Pulike Biological Engineering Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pulike Biological Engineering's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2723.875/3262.209
=0.83

Pulike Biological Engineering's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=2733.413/3205.137
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulike Biological Engineering  (SHSE:603566) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Pulike Biological Engineering Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines